R&D
AstraZeneca to retire MedImmune brand amid restructuring
February 15, 2019Medical Communications AstraZeneca, Business, MedImmune, R&D, biologics, restructuring
AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D …
UCB to invest £1 billion into UK R&D
December 6, 2018Manufacturing and Production, Research and Development R&D, UCB, UK, brussels, investment, research
The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector …
83% in healthcare say UK will not be attractive for R&D and manufacturing post-Brexit
November 30, 2018Medical Communications, Research and Development R&D, UK, brexit, pharma
As the Brexit crisis continues to spiral, new findings from GlobalData reveal that 83% of healthcare professionals in the UK …
GSK retain top spot on access to medicines list
November 22, 2018Business Services, Research and Development GSK, J&J, JJ, R&D, Sanofi, access, low and middle income countries, researh
The majority (63%) of research and development projects are being conducted by just five companies; GSK, Johnson & Johnson, Sanofi, …
Rising to the challenge of delivering therapeutic discovery for mental disorders
November 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health
Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …
Ipsen appoints two leading R&D experts in bid to strengthen oncology arm
September 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, R&D, development, ipsen, oncology, research
French pharma firm Ipsen has announced the appointment of Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic …
Takeda’s lung cancer treatment Alunbrig proves successful in Phase III trial
September 26, 2018Research and Development Alunbrig, R&D, Takeda, phase III, research
Japanese pharma firm Takeda have announced that lung cancer treatment Alunbrig has proven successful in reducing the risk of disease …
Amgen announces resignation of two top executives
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Anthony C Cooper, R&D, biotech, retire, sean harper
Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …
AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide
October 24, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC
New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …
The pharmaceutical research and development challenge
June 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile
This report from Kalorama Information was featured in the Spring 2017 edition of Pharmafile. Despite new approaches, new technologies and …
Enhancing scientific acumen in the pharma boardroom
March 17, 2017Medical Communications R&D
Dana M. Krueger and Neha Rajdev, of Russell Reynolds, discuss the importance of a scientific background in the boardrooms of …
Pharmaceutical R&D tax credit regulatory legislation: The need for clarity
January 20, 2017Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile
Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …
New head of R&D at Biogen
April 27, 2016Research and Development Biogen, Pfizer, R&D, erhlers, michael, michael erhlers, research and development
Biogen (NASDAQ: BIIB) has announced the appointment of Dr Michael Ehlers as executive vice president, research and development. His role …
Allergan to partner with Heptares in Alzheimer’s disease collaboration
April 7, 2016Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Alzheimer's, Heptares, R&D, collaboration, commercialisation, h1, h4, neurological disorders, partnership, research and development, treatments
Bouncing back quickly from the collapse of the collapse of the Pfizer inversion deal, Allergan (NYSE:AGN) has announced a new …
Cancer – dealing with the greatest health challenge of our time
February 4, 2016Manufacturing and Production, Research and Development Cancer, IFPMA, R&D, World Cancer Day, collaboration, partnership
Cancer is one of the greatest health challenges of our time, and a leading cause of death in every corner …
